SERS Detection of the Anti-Epileptic Drug Perampanel in Human Saliva

被引:4
|
作者
Tommasini, Matteo [1 ]
Lucotti, Andrea [1 ]
Stefani, Luca [2 ]
Trusso, Sebastiano [3 ]
Ossi, Paolo M. [2 ,4 ]
机构
[1] Politecn Milan, Dipartimento Chim, Mat, Ingn Chim, I-20133 Milan, Italy
[2] Politecn Milan, Dipartimento Energia, I-20133 Milan, Italy
[3] CNR, Ist Proc Chim Fis, I-98158 Messina, Italy
[4] Univ Messina, Dipartimento Sci Chim Biol Farmaceut & Ambientali, I-98166 Messina, Italy
来源
MOLECULES | 2023年 / 28卷 / 11期
关键词
Surface Enhanced Raman Scattering (SERS); Therapeutic Drug Monitoring (TDM); Anti-Epileptic Drug (AED); Perampanel; human saliva;
D O I
10.3390/molecules28114309
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Surface-Enhanced Raman Scattering (SERS) can obtain the spectroscopic response of specific analytes. In controlled conditions, it is a powerful quantitative technique. However, often the sample and its SERS spectrum are complex. Pharmaceutical compounds in human biofluids with strong interfering signals from proteins and other biomolecules are a typical example. Among the techniques for drug dosage, SERS was reported to detect low drug concentrations, with analytical capability comparable to that of the assessed High-Performance Liquid Chromatography. Here, for the first time, we report the use of SERS for Therapeutic Drug Monitoring of the Anti-Epileptic Drug Perampanel (PER) in human saliva. We used inert substrates decorated with gold NPs deposited via Pulsed Laser Deposition as SERS sensors. We show that it is possible to detect PER in saliva via SERS after an optimized treatment of the saliva sample. Using a phase separation process, it is possible to extract all the diluted PER in saliva from the saliva phase to a chloroform phase. This allows us to detect PER in the saliva at initial concentrations of the order of 10(-7) M, thus approaching those of clinical interest.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Sensing the Anti-Epileptic Drug Perampanel with Paper-Based Spinning SERS Substrates
    Macrelli, Andrea
    Villa, Nicolo Simone
    Lucotti, Andrea
    Dellasega, David
    Ossi, Paolo Maria
    Tommasini, Matteo
    MOLECULES, 2022, 27 (01):
  • [2] MYLEPSIN AS AN ANTI-EPILEPTIC DRUG
    DREYER, R
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1956, 81 (42) : 1681 - 1683
  • [3] CORRELATES OF ANTI-EPILEPTIC DRUG COMPLIANCE
    SHOPE, J
    FERGUSON, K
    LEPPIK, I
    HAUSER, W
    VANDYNE, B
    EPILEPSIA, 1982, 23 (04) : 439 - 439
  • [4] Anti-Epileptic Drug Toxicity in Children
    Choonara, Imti
    CHILDREN-BASEL, 2018, 5 (05):
  • [5] An assessment of levetiracetam as an anti-epileptic drug
    Jain, KK
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2000, 9 (07) : 1611 - 1624
  • [6] Advances in anti-epileptic drug testing
    Krasowski, Matthew D.
    McMillin, Gwendolyn A.
    CLINICA CHIMICA ACTA, 2014, 436 : 224 - 236
  • [7] Tiagabina: A GABAergic anti-epileptic drug
    Herranz, JL
    REVISTA DE NEUROLOGIA, 1997, 25 (146) : 1607 - 1610
  • [8] Topiramato, a new anti-epileptic drug
    Herranz, JL
    REVISTA DE NEUROLOGIA, 1997, 25 (144) : 1221 - 1225
  • [9] Anti-epileptic drug monitoring and interactions in epileptic therapy
    Patsalos, PN
    BRITISH JOURNAL OF PHARMACOLOGY, 2000, 131 : U74 - U74
  • [10] Validating a decision support system for anti-epileptic drug treatment Part I: initiating anti-epileptic drug treatment
    Smeets, R
    Talmon, J
    Meinardi, H
    Hasman, A
    INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS, 1999, 55 (03) : 189 - 198